Literature DB >> 11926998

Inhibition of proteasomes induces accumulation, phosphorylation, and recruitment of HSP27 and alphaB-crystallin to aggresomes.

Hidenori Ito1, Keiko Kamei, Ikuko Iwamoto, Yutaka Inaguma, Rafael García-Mata, Elizabeth Sztul, Kanefusa Kato.   

Abstract

Molecular chaperones and the ubiquitin-proteasome pathway are known to participate in the quality control of proteins in cells. In this study, we examined the responses of small heat shock proteins to proteasome inhibitors to clarify their roles under conditions where misfolded proteins are abnormally accumulated. HSP27 and alphaB-crystallin accumulated in both soluble and, more prominently, insoluble fractions after exposure to MG-132, a proteasome inhibitor. Enhanced expression of mRNAs for HSP27 and alphaB-crystallin was observed, suggesting transcriptional activation. Phosphorylation of HSP27 and alphaB-crystallin in cells treated with MG-132 was enhanced concomitantly with activation of p38 and p44/42 MAP kinase pathways. Immunofluorescence analysis revealed that exposure to proteasome inhibitors induced the formation of aggresomes in U373 MG cells, to which HSP27 and alphaB-crystallin were recruited. However, phosphorylation was not required for this accumulation in aggresomes. Thus, HSP27 and alphaB-crystallin are increased, phosphorylated and localized in aggresomes when proteasome activity is inhibited.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11926998     DOI: 10.1093/oxfordjournals.jbchem.a003139

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  25 in total

Review 1.  Novel roles for α-crystallins in retinal function and disease.

Authors:  Ram Kannan; Parameswaran G Sreekumar; David R Hinton
Journal:  Prog Retin Eye Res       Date:  2012-06-18       Impact factor: 21.198

Review 2.  Regulation of αA- and αB-crystallins via phosphorylation in cellular homeostasis.

Authors:  Erin Thornell; Andrew Aquilina
Journal:  Cell Mol Life Sci       Date:  2015-07-26       Impact factor: 9.261

3.  A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease.

Authors:  Barbara A Cottrell; Veronica Galvan; Surita Banwait; Olivia Gorostiza; Christian R Lombardo; Tristan Williams; Birgit Schilling; Alyson Peel; Bradford Gibson; Edward H Koo; Christopher D Link; Dale E Bredesen
Journal:  Ann Neurol       Date:  2005-08       Impact factor: 10.422

Review 4.  Heat shock protein 27: its potential role in vascular disease.

Authors:  Gordon Ferns; Sedigheh Shams; Shahida Shafi
Journal:  Int J Exp Pathol       Date:  2006-08       Impact factor: 1.925

5.  Septin 14 is involved in cortical neuronal migration via interaction with Septin 4.

Authors:  Tomoyasu Shinoda; Hidenori Ito; Kaori Sudo; Ikuko Iwamoto; Rika Morishita; Koh-ichi Nagata
Journal:  Mol Biol Cell       Date:  2010-02-24       Impact factor: 4.138

6.  HSPA1A-independent suppression of PARK2 C289G protein aggregation by human small heat shock proteins.

Authors:  Melania Minoia; Corien Grit; Harm H Kampinga
Journal:  Mol Cell Biol       Date:  2014-07-14       Impact factor: 4.272

7.  AbetaPP-overexpression and proteasome inhibition increase alphaB-crystallin in cultured human muscle: relevance to inclusion-body myositis.

Authors:  Slawomir Wojcik; W King Engel; Janis McFerrin; Orlando Paciello; Valerie Askanas
Journal:  Neuromuscul Disord       Date:  2006-10-23       Impact factor: 4.296

8.  Proteasome inhibition induces hsp30 and hsp70 gene expression as well as the acquisition of thermotolerance in Xenopus laevis A6 cells.

Authors:  Jordan T F Young; John J Heikkila
Journal:  Cell Stress Chaperones       Date:  2009-10-18       Impact factor: 3.667

9.  Desmin aggregate formation by R120G alphaB-crystallin is caused by altered filament interactions and is dependent upon network status in cells.

Authors:  Ming Der Perng; Shu Fang Wen; Paul van den IJssel; Alan R Prescott; Roy A Quinlan
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

Review 10.  Protein quality control system in neurodegeneration: a healing company hard to beat but failure is fatal.

Authors:  Deepak Chhangani; Amit Mishra
Journal:  Mol Neurobiol       Date:  2013-02-03       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.